
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dioscorea Extract
Therapeutic Area : Neurology
Study Phase : Phase II
Recipient : NeuroBo Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Merger
Details : NeuroBo will focus on advancing the company’s clinical-stage pipeline for neurodegenerative diseases.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Undisclosed
January 10, 2020
Lead Product(s) : Dioscorea Extract
Therapeutic Area : Neurology
Highest Development Status : Phase II
Recipient : NeuroBo Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Merger

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Gemcabene
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Recipient : Gabrail Cancer Center Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Gemcabene for the Treatment of Pediatric NAFLD
Details : Gemcabene is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 19, 2018
Lead Product(s) : Gemcabene
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Recipient : Gabrail Cancer Center Research
Deal Size : Inapplicable
Deal Type : Inapplicable
